Menu

Radiation Risk for Mars Astronauts

An instrument aboard the spaceship that carried Curiosity to Mars has found that deep space travelers would face worrying levels of radiation.

Jun 3, 2013
Kate Yandell

NASA/JPL-CALTECH/MSSS NASA has planned to someday send a manned mission to Mars, but radiation has long been a concern. A Radiation Assessment Detector aboard the vessel that took Curiosity to the planet has measured the radiation exposure received on the trip as being high enough to be prohibitive to humans, Wired Science reported—at least with current NASA rules and spacecraft equipment.

A person traveling to Mars and back who did not ever get off the spacecraft would be exposed to .66 sieverts, according to the instrument. The highest dose a male NASA astronaut is permitted to experience over a lifetime currently is 1.2 sieverts; females can be exposed to only 1 sievert. If the astronaut landed on Mars and explored, the dose would be much higher.

“If, as the authors suggest, the MSL data correspond to the dose to be expected by astronauts on a similarly shielded vehicle under similar conditions, then that dose is still unacceptable by NASA standards,” John Charles of NASA’s Johnson Space Center in Texas told Nature.

The main fear is cancer, but radiation can also cause short-term memory loss and other health problems.

NASA has estimated the radiation involved in such a trip before, but this is the first time they have gotten measurements from an instrument shielded the same way human astronauts would be shielded on a journey to Mars. The results are at the high end of previous estimates but not unexpected, Nature reported.

Sheila Thibeault, a physicist from NASA’s Langley Research Center in Virginia, told Nature that one solution would be better radiation shielding for any spacecraft carrying astronauts. She and colleagues are testing hydrogenated materials as materials in hopes that they will be light enough for space flight and capable of blocking radiation more effectively than current options.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!